|
|
|
Volumn 36, Issue SUPPL. 2, 1999, Pages 19-22
|
|
Historical perspective on the treatment of essential thrombocythemia and polycythemia vera
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANAGRELIDE;
BUSULFAN;
HYDROXYUREA;
MELPHALAN;
PHOSPHORUS 32;
RECOMBINANT ALPHA INTERFERON;
CHILL;
DRUG COST;
DRUG SAFETY;
DRUG TOLERABILITY;
FEVER;
FLU LIKE SYNDROME;
GASTROINTESTINAL HEMORRHAGE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
IMMUNOMODULATION;
LEUKEMIA;
LONG TERM EXPOSURE;
LYMPHOMA;
MYALGIA;
POLYCYTHEMIA VERA;
POPULATION RISK;
PRIORITY JOURNAL;
REVIEW;
RISK BENEFIT ANALYSIS;
THROMBOCYTHEMIA;
HUMANS;
POLYCYTHEMIA VERA;
RISK ASSESSMENT;
THROMBOCYTHEMIA, HEMORRHAGIC;
|
|
EID: 0032925412
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (17)
|
|
References (32)
|
